What is the first-line medical expulsive therapy for distal ureteral stones and its mechanism?

Prepare for the Urology and Nephrology Test with focused study materials. Utilize flashcards and multiple-choice questions featuring hints and explanations. Ensure your readiness for the examination.

Multiple Choice

What is the first-line medical expulsive therapy for distal ureteral stones and its mechanism?

Explanation:
First-line medical expulsive therapy for distal ureteral stones is an alpha-1 adrenergic blocker that relaxes the ureteral smooth muscle to aid passage. Tamsulosin does this by blocking alpha-1 receptors in the distal ureter, especially the alpha-1D subtype that’s prevalent there. With the smooth muscle relaxed, ureteral tone and spasm decrease, so the stone has an easier path to move down into the bladder. This intervention often shortens the time to passage and can reduce the need for surgical intervention, while allowing continued movement of urine and relief of painful spasms. Other options mainly address pain (an NSAID or an opioid) or have less strong evidence for actively promoting stone passage (calcium channel blockers like nifedipine), so they’re not considered first-line for expulsion.

First-line medical expulsive therapy for distal ureteral stones is an alpha-1 adrenergic blocker that relaxes the ureteral smooth muscle to aid passage. Tamsulosin does this by blocking alpha-1 receptors in the distal ureter, especially the alpha-1D subtype that’s prevalent there. With the smooth muscle relaxed, ureteral tone and spasm decrease, so the stone has an easier path to move down into the bladder. This intervention often shortens the time to passage and can reduce the need for surgical intervention, while allowing continued movement of urine and relief of painful spasms. Other options mainly address pain (an NSAID or an opioid) or have less strong evidence for actively promoting stone passage (calcium channel blockers like nifedipine), so they’re not considered first-line for expulsion.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy